Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05242952 · ClinicalTrials.gov registry record · NA
The LEARN Study for CVD Prevention
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT05242952: Completed NA study, sponsored by Yale University.
NCT05242952 is a NA study that has completed, run by Yale University. The registered enrollment target is 78 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05242952, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
The investigator is testing a virtual environment to address prevention of HIV-related comorbidities.
Primary Outcome
Feasibility was operationalized through recruitment metrics (proportion of individuals who enrolled from those initially contacted) and retention metrics (percentage of participants who completed 3-month and 6-month follow-up assessments from baseline analysis sample).
Interventions
- BEHAVIORAL Gaming in a virtual environment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2023-05-10 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
What the finished NCT05242952 record still lists
NCT05242952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Gaming in a virtual environment is the first listed.
NCT05242952 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05242952 about?
NCT05242952 is a clinical study titled "The LEARN Study for CVD Prevention". The investigator is testing a virtual environment to address prevention of HIV-related comorbidities.
What is the current status of trial NCT05242952?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2023-05-10. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT05242952?
The interventions under investigation include: Gaming in a virtual environment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05242952?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05242952's enrollment target sits among peer trials
78 1060th of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI